Guangzhou Ruianbo Pharmaceutical TechnologyOrganizationGet new research by emailTrialsPhase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and HyperuricemiaPhase 2/3, Status unknown, 636 people, Sep 19, 2024Sources: clinicaltrials.gov